Professor Mikkel Østergaard
3 clinical trials · Sponsor
◉ Watch Professor Mikkel Østergaard
| Record | Firm | Date |
|---|---|---|
| Treat-to-target With Secukinumab in Axial Spondyloarthritis (NCT03639740) | Professor Mikkel Østergaard | 2019-01-15 |
| Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) (NCT04515732) | Professor Mikkel Østergaard | 2018-12-14 |
Track Professor Mikkel Østergaard automatically
Every clearance here is in the API, with alerts when new ones post.